Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Molecular Carcinogenesis
|
June 16, 2009
Using cells devoid of RAS proteins as tools for drug discovery
Jelena Urosevic, Eleanor Y M Sum, Victoria Moneo, et al.
Plos Genetics
|
March 10, 2017
A new mode of DNA binding distinguishes Capicua from other HMG-box factors and explains its mutation patterns in cancer
Marta Forés, Lucía Simón-Carrasco, Leiore Ajuria, et al.
Genes & Development
|
August 23, 2017
Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma
Lucía Simón-Carrasco, Osvaldo Graña, Marina Salmón, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 24, 2020
Requirement for epithelial p38α in KRAS-driven lung tumor progression
Jessica Vitos-Faleato, Sebastián M Real, Nuria Gutierrez-Prat, et al.
Journal of the National Cancer Institute
|
August 19, 2004
Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma
Matthias Drosten, Gero Hilken, Miriam Böckmann, et al.
Human Gene Therapy
|
November 2, 2005
Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection
Miriam Böckmann, Gero Hilken, Anke Schmidt, et al.
Genes & Development
|
April 14, 2018
ERF deletion rescues RAS deficiency in mouse embryonic stem cells
Cristina Mayor-Ruiz, Teresa Olbrich, Matthias Drosten, et al.
Molecular Oncology
|
March 21, 2022
KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors
Guillem Paniagua, Harrys K C Jacob, Oksana Brehey, et al.
The EMBO Journal
|
February 13, 2010
Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival
Matthias Drosten, Alma Dhawahir, Eleanor Y M Sum, et al.
Molecular Cell
|
December 27, 2011
Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras
David Matallanas, David Romano, Fahd Al-Mulla, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Molecular Carcinogenesis
|
June 16, 2009
Using cells devoid of RAS proteins as tools for drug discovery
Jelena Urosevic, Eleanor Y M Sum, Victoria Moneo, et al.
Plos Genetics
|
March 10, 2017
A new mode of DNA binding distinguishes Capicua from other HMG-box factors and explains its mutation patterns in cancer
Marta Forés, Lucía Simón-Carrasco, Leiore Ajuria, et al.
Genes & Development
|
August 23, 2017
Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma
Lucía Simón-Carrasco, Osvaldo Graña, Marina Salmón, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 24, 2020
Requirement for epithelial p38α in KRAS-driven lung tumor progression
Jessica Vitos-Faleato, Sebastián M Real, Nuria Gutierrez-Prat, et al.
Journal of the National Cancer Institute
|
August 19, 2004
Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma
Matthias Drosten, Gero Hilken, Miriam Böckmann, et al.
Human Gene Therapy
|
November 2, 2005
Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection
Miriam Böckmann, Gero Hilken, Anke Schmidt, et al.
Genes & Development
|
April 14, 2018
ERF deletion rescues RAS deficiency in mouse embryonic stem cells
Cristina Mayor-Ruiz, Teresa Olbrich, Matthias Drosten, et al.
Molecular Oncology
|
March 21, 2022
KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors
Guillem Paniagua, Harrys K C Jacob, Oksana Brehey, et al.
The EMBO Journal
|
February 13, 2010
Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival
Matthias Drosten, Alma Dhawahir, Eleanor Y M Sum, et al.
Molecular Cell
|
December 27, 2011
Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras
David Matallanas, David Romano, Fahd Al-Mulla, et al.
Page
of 5